Placenta Market Size Will Witness Substantial Growth in the Upcoming Years by 2034
Placenta Market Size Will Witness Substantial Growth in the Upcoming Years by 2034
Blog Article
Market Overview
The placenta, a temporary organ formed during pregnancy, is rich in proteins, amino acids, nucleic acids, hormones, and growth factors. These biological components make it a valuable resource for multiple therapeutic and commercial applications. Placental extracts—sourced from human or animal origins—are processed into pharmaceutical-grade injectables, topical solutions, creams, and capsules for a wide range of uses.
Global Placenta Market size and share is currently valued at USD 599.45 million in 2024 and is anticipated to generate an estimated revenue of USD 652.21 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 8.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Market Trends & Opportunities
- Rising Demand for Regenerative and Anti-Aging Therapies
One of the most prominent trends in the placenta market is the growing interest in regenerative treatments, especially in the fields of dermatology, orthopedics, and wound care. Placental extracts, including amniotic fluid and membrane components, are used to promote cell regeneration, enhance tissue repair, and reduce inflammation.
In cosmetics and skincare, placenta-based creams, masks, and serums are gaining popularity for their anti-aging and skin-rejuvenation effects. Brands are positioning these products as natural alternatives to synthetic compounds, appealing to consumers seeking clean-label and biologically active skincare.
- Expanding Research into Placental Stem Cells
The placenta is a rich source of mesenchymal stem cells (MSCs), which possess immunomodulatory and regenerative potential. These cells are being studied for their applications in treating conditions such as neurological disorders, cardiovascular diseases, autoimmune conditions, and even COVID-19-related lung damage.
As the field of stem cell therapy evolves, placenta-derived stem cells are expected to play a significant role due to their ethical viability, ease of harvest, and potent biological activity.
- Growing Use in Nutraceuticals and Functional Foods
Animal-derived placental extracts are increasingly incorporated into dietary supplements targeting vitality, hormonal balance, and postpartum recovery. These supplements are particularly popular in Asian markets like Japan, South Korea, and China, where traditional medicine systems embrace placenta for its holistic healing benefits.
Product innovations include placenta-enriched capsules, beverages, and powders aimed at enhancing stamina, skin health, and immune function.
- Rising Acceptance of Human-Derived Biologics
With improved ethical sourcing, advanced processing techniques, and stricter regulatory compliance, the acceptance of human placenta-derived biologics has increased in clinical practice. Hospitals and wound care centers now utilize amniotic membrane allografts and topical placenta therapies for chronic wounds, burns, diabetic ulcers, and ophthalmic procedures.
Future Scope of the Placenta Market
The placenta market is poised for dynamic growth, driven by:
- Technological innovation in extraction, purification, and preservation methods to ensure bioactivity and safety.
- Expansion into personalized medicine, where placenta-based biologics can be tailored for individual patient needs.
- Regulatory harmonization, particularly in Europe and North America, which will encourage cross-border trade and product approvals.
- Increasing collaborations between biotech startups, research institutions, and pharma companies to commercialize novel placenta-based treatments.
- Rising demand in veterinary care, where placental extracts are used for animal recovery, reproductive health, and performance enhancement.
As healthcare systems prioritize minimally invasive and biologically compatible therapies, placenta-derived products will play a vital role across both preventive and therapeutic applications.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/placenta-market
Market Segmentation
The placenta market can be segmented by source, application, product type, and end-user.
- By Source
- Human Placenta
- Porcine Placenta
- Ovine Placenta
- Bovine Placenta
Human placenta dominates the biopharmaceutical segment, while animal placentas—particularly bovine and porcine—are commonly used in cosmeceuticals and dietary supplements.
- By Product Type
- Placental Extracts
- Placenta-Based Capsules/Tablets
- Amniotic Membranes
- Placenta Creams/Serums
- Injectable Biologics
Topical and oral forms are prevalent in cosmetics and nutraceuticals, while injectable and membrane-based products are increasingly used in hospitals and clinical settings.
- By Application
- Cosmeceuticals (Skin Repair, Anti-Aging)
- Wound Healing and Burn Care
- Orthopedic and Surgical Applications
- Stem Cell Therapy
- Postpartum Recovery
- Nutraceuticals and Supplements
The cosmeceutical segment holds a dominant market share, followed closely by wound care and therapeutic applications in regenerative medicine.
- By End-User
- Hospitals & Clinics
- Cosmetic Companies
- Pharmaceutical Companies
- Research Institutes
- Dietary Supplement Manufacturers
Hospitals and pharmaceutical firms are leading consumers of therapeutic placenta-based products, while cosmetic and nutraceutical manufacturers drive volume demand.
Regional Analysis
Asia-Pacific
Asia-Pacific is the largest and fastest-growing region in the placenta market. Countries such as Japan, China, and South Korea are early adopters of placenta-based products, especially in cosmetics and supplements. Japan, in particular, has a long tradition of using animal placenta in skincare and health products, supported by a strong domestic manufacturing base and regulatory acceptance.
North America
The North American market is growing steadily, with increased adoption of placental biologics in orthopedic and wound care. The U.S. is witnessing rising investments in placental stem cell therapy, and the presence of advanced research institutions is supporting innovation in regenerative medicine.
Europe
Europe has a well-regulated medical market and is increasingly adopting human placental membranes for surgical and ophthalmic use. Countries like Germany, France, and the UK are fostering R&D through grants and public-private partnerships.
Latin America & Middle East
These emerging regions show potential for market expansion, particularly in cosmeceuticals and postpartum care. Rising awareness about natural and biologically active ingredients is expected to fuel demand.
Key Companies in the Placenta Market
Leading companies in the placenta market are innovating across multiple verticals—biotech, cosmetics, and nutraceuticals—to tap into growing global demand. Their strategic priorities include:
- Albert David Limited
- Atlanta Placenta Encapsulation
- Japan Bio Products Co., Ltd.
- Japan Natural Laboratories Co., Ltd.
- MIMEDX Group, Inc.
- Mommy Made Encapsulation
- Nubloom LLC
- PURTIER Placenta
- Smith and Nephew
- The Placenta Company
Conclusion
The global placenta market stands at the intersection of traditional knowledge and modern science, offering powerful therapeutic and cosmetic benefits that are increasingly backed by clinical research. As consumers demand more natural, effective, and biologically active health and beauty solutions, placenta-derived products are gaining broad acceptance.
More Trending Latest Reports By Polaris Market Research:
Wetsuit Market
Property Management Software Market
Fire Department Software Market
Gas Turbine Market
Alloy Steel Market
Edtech And Smart Classroom Market
Conformal Coatings Market
Conformal Coatings Market
Gas Turbine Market
Medical Devices Market
U.S. Metaverse Market
ModelOPs Market
Amaranth Market
Micro-pumps Market
Automotive Biometrics Market
Conformal Coatings Market
Conformal Coatings Market
Amaranth Market Report this page